Dr. José Angel Garza-Ruiz

Claim this profile

GSK Investigational Site

Studies Chronic Obstructive Pulmonary Disease
1 reported clinical trial
1 drug studied

More about José Angel Garza-Ruiz

Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments José Angel Garza-Ruiz has experience with
  • Mepolizumab
Breakdown of trials José Angel Garza-Ruiz has run
Chronic Obstructive Pulmonary Disease

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does José Angel Garza-Ruiz specialize in?
José Angel Garza-Ruiz focuses on Chronic Obstructive Pulmonary Disease and other conditions. In particular, much of their work with Chronic Obstructive Pulmonary Disease has involved treating patients, or patients who are undergoing treatment.
Is José Angel Garza-Ruiz currently recruiting for clinical trials?
No, José Angel Garza-Ruiz is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that José Angel Garza-Ruiz has studied deeply?
Yes, José Angel Garza-Ruiz has studied treatments such as Mepolizumab.
What is the best way to schedule an appointment with José Angel Garza-Ruiz?
Apply for one of the trials that José Angel Garza-Ruiz is conducting.
What is the office address of José Angel Garza-Ruiz?
The office of José Angel Garza-Ruiz is located at: GSK Investigational Site, Monterrey, Nuevo León 64460 Mexico. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.